These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36548327)

  • 1. Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional Survey.
    Hohmann LA; Krauss Z; Patel J; Marley GT
    Pharmacy (Basel); 2022 Dec; 10(6):. PubMed ID: 36548327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public perceptions of naloxone use in the outpatient setting.
    Smith JO; Malinowski SS; Ballou JM
    Ment Health Clin; 2019 Jul; 9(4):275-279. PubMed ID: 31293847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
    Green TC; Case P; Fiske H; Baird J; Cabral S; Burstein D; Schwartz V; Potter N; Walley AY; Bratberg J
    J Am Pharm Assoc (2003); 2017; 57(2S):S19-S27.e4. PubMed ID: 28214219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public attitudes and beliefs about Virginia community pharmacists dispensing and administering naloxone.
    Haggerty LC; Gatewood SS; Goode JKR
    J Am Pharm Assoc (2003); 2018; 58(4S):S73-S77.e1. PubMed ID: 30006189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views of the Scottish general public on community pharmacy weight management services: international implications.
    Weidmann AE; Cunningham S; Gray G; Hansford D; Bermano G; Stewart D
    Int J Clin Pharm; 2012 Apr; 34(2):389-97. PubMed ID: 22382887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' knowledge, support, and perceived roles associated with providing naloxone in the community.
    Stewart B; Thomas RL; Tutag-Lehr V
    Curr Pharm Teach Learn; 2018 Aug; 10(8):1013-1021. PubMed ID: 30314535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study.
    Burstein D; Baird J; Bratberg J; Donovan E; Soipe A; Tapper A; Case P; Walley AY; Green TC
    J Am Pharm Assoc (2003); 2020; 60(2):304-310. PubMed ID: 31870862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of Alberta pharmacists' attitudes, comfort and perceived barriers to a community-based naloxone program.
    Nowlan SE; MacKinnon NJ; Hincapie A; Tachuk M
    Can Pharm J (Ott); 2021; 154(4):262-270. PubMed ID: 34345319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicine-related services in community pharmacy: public preferences for pharmacy attributes and promotional methods and comparison with pharmacists' perceptions.
    Gammie SM; Rodgers RM; Loo RL; Corlett SA; Krska J
    Patient Prefer Adherence; 2016; 10():2297-2307. PubMed ID: 27877021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists.
    Bakhireva LN; Bautista A; Cano S; Shrestha S; Bachyrycz AM; Cruz TH
    Subst Abus; 2018; 39(3):331-341. PubMed ID: 29043922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dispensing Naloxone Without a Prescription: Survey Evaluation of Ohio Pharmacists.
    Thompson EL; Rao PSS; Hayes C; Purtill C
    J Pharm Pract; 2019 Aug; 32(4):412-421. PubMed ID: 29478362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians.
    Kurian S; Baloy B; Baird J; Burstein D; Xuan Z; Bratberg J; Tapper A; Walley A; Green TC
    J Am Pharm Assoc (2003); 2019; 59(6):824-831. PubMed ID: 31582224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of naloxone availability in Georgia community pharmacies.
    Stone RH; Hur S; Young HN
    J Am Pharm Assoc (2003); 2020; 60(2):357-361. PubMed ID: 31866387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Student pharmacist perceptions of participation in hands-on naloxone counseling.
    Hines J; Deja E; Black EP
    Curr Pharm Teach Learn; 2018 Jun; 10(6):712-716. PubMed ID: 30025770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy on-site overdose protocols and prevention of overdose.
    Green TC; Soipe A; Baloy B; Burstein D; Xuan Z; Tapper A; Walley AY; Case P; Bratberg J; Baird J
    Subst Abus; 2022; 43(1):64-68. PubMed ID: 32186478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia.
    Selvaraj A; Redzuan AM; Hatah E
    Int J Clin Pharm; 2020 Apr; 42(2):777-785. PubMed ID: 32006142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of the Malaysian general public on community pharmacy-based weight management services.
    Verma RK; Paraidathathu T; Taha NA; Chong WW
    J Pharm Policy Pract; 2018; 11():17. PubMed ID: 30094032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.